CD274 and neoplasm: Using the TIDE algorithm (25), we analyzed the correlation between RFPL3S expression and immunotherapy, and observed that the higher RFPL3S expression was associated with lower TIDE score and escape score in TGCT patients (Figure 6C), while was associated with higher the expression of the anti-tumor immune response markers CD274 and IFN-γ (Figure 6C).